Alembic Pharmaceuticals informs about press release

23 Apr 2021 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Doxepin Hydrochloride Capsules USP, 10 mg, 25 mg, 50 mg, 75 mg and 100 mg. In this regard, the company has enclosed a press release on 23rd April 2021.

The above information is a part of company’s filings submitted to BSE.





Alembic Pharma Share Price

769.05 6.15 (0.81%)
23-Feb-2026 12:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1726.00
Dr. Reddys Lab 1294.20
Cipla 1321.95
Zydus Lifesciences 901.95
Lupin 2234.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×